576 related articles for article (PubMed ID: 28075057)
1. Two-Dimensional Nanomaterials for Cancer Nanotheranostics.
Chen Y; Wu Y; Sun B; Liu S; Liu H
Small; 2017 Mar; 13(10):. PubMed ID: 28075057
[TBL] [Abstract][Full Text] [Related]
2. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy.
Murugan C; Sharma V; Murugan RK; Malaimegu G; Sundaramurthy A
J Control Release; 2019 Apr; 299():1-20. PubMed ID: 30771414
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
Ma Y; Huang J; Song S; Chen H; Zhang Z
Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
[TBL] [Abstract][Full Text] [Related]
4. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
5. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy.
Muthu MS; Mehata AK; Viswanadh MK
Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815
[No Abstract] [Full Text] [Related]
6. Recent Advances of Emerging Metal-Containing Two-Dimensional Nanomaterials in Tumor Theranostics.
Li C; Fang X; Zhang H; Zhang B
Int J Nanomedicine; 2024; 19():805-824. PubMed ID: 38283201
[TBL] [Abstract][Full Text] [Related]
7. Current status of Cancer Nanotheranostics: Emerging strategies for cancer management.
Chavda VP; Khadela A; Shah Y; Postwala H; Balar P; Vora L
Nanotheranostics; 2023; 7(4):368-379. PubMed ID: 37151802
[TBL] [Abstract][Full Text] [Related]
8. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
[TBL] [Abstract][Full Text] [Related]
9. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.
Ang MJY; Chan SY; Goh YY; Luo Z; Lau JW; Liu X
Adv Drug Deliv Rev; 2021 Nov; 178():113907. PubMed ID: 34371084
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Carbon Nanomaterials for Cancer Phototherapy.
Jiang BP; Zhou B; Lin Z; Liang H; Shen XC
Chemistry; 2019 Mar; 25(16):3993-4004. PubMed ID: 30328167
[TBL] [Abstract][Full Text] [Related]
11. Copper Manganese Sulfide Nanoplates: A New Two-Dimensional Theranostic Nanoplatform for MRI/MSOT Dual-Modal Imaging-Guided Photothermal Therapy in the Second Near-Infrared Window.
Ke K; Yang W; Xie X; Liu R; Wang LL; Lin WW; Huang G; Lu CH; Yang HH
Theranostics; 2017; 7(19):4763-4776. PubMed ID: 29187902
[TBL] [Abstract][Full Text] [Related]
12. Bioinspired approaches for cancer nanotheranostics.
Evangelopoulos M; Tasciotti E
Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
[No Abstract] [Full Text] [Related]
13. "Trojan Horse" DNA Nanostructure for Personalized Theranostics: Can It Knock on the Door of Preclinical Practice?
Li Y; Yang S; Zheng J; Zou Z; Yang R; Tan W
Langmuir; 2018 Dec; 34(49):15028-15044. PubMed ID: 30295491
[TBL] [Abstract][Full Text] [Related]
14. Facile Supramolecular Approach to Nucleic-Acid-Driven Activatable Nanotheranostics That Overcome Drawbacks of Photodynamic Therapy.
Li X; Yu S; Lee D; Kim G; Lee B; Cho Y; Zheng BY; Ke MR; Huang JD; Nam KT; Chen X; Yoon J
ACS Nano; 2018 Jan; 12(1):681-688. PubMed ID: 29232105
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared light-responsive nanomaterials for cancer theranostics.
Kim H; Chung K; Lee S; Kim DH; Lee H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):23-45. PubMed ID: 25903643
[TBL] [Abstract][Full Text] [Related]
16. Nanohybrids - cancer theranostics for tiny tumor clusters.
Dhandapani R; Sethuraman S; Subramanian A
J Control Release; 2019 Apr; 299():21-30. PubMed ID: 30797000
[TBL] [Abstract][Full Text] [Related]
17. Graphene-like Metal-Free 2D Nanosheets for Cancer Imaging and Theranostics.
Luo Y; Li Z; Zhu C; Cai X; Qu L; Du D; Lin Y
Trends Biotechnol; 2018 Nov; 36(11):1145-1156. PubMed ID: 29954613
[TBL] [Abstract][Full Text] [Related]
18. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
[TBL] [Abstract][Full Text] [Related]
19. Chemical Modification of Chitosan for Developing Cancer Nanotheranostics.
Li X; Wang Y; Feng C; Chen H; Gao Y
Biomacromolecules; 2022 Jun; 23(6):2197-2218. PubMed ID: 35522524
[TBL] [Abstract][Full Text] [Related]
20. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
